ABSTRACT
Interpretation of variants of uncertain significance, especially chromosomal rearrangements in non-coding regions of the human genome, remains one of the biggest challenges in modern molecular diagnosis. To improve our understanding and interpretation of such variants, we used high-resolution three-dimensional chromosomal structural data and transcriptional regulatory information to predict position effects and their association with pathogenic phenotypes in 17 subjects with apparently balanced chromosomal abnormalities. We found that the rearrangements predict disruption of long-range chromatin interactions between several enhancers and genes whose annotated clinical features are strongly associated with the subjects' phenotypes. We confirm gene-expression changes for a couple of candidate genes to exemplify the utility of our analysis of position effect. These results highlight the important interplay between chromosomal structure and disease and demonstrate the need to utilize chromatin conformational data for the prediction of position effects in the clinical interpretation of non-coding chromosomal rearrangements.
Subject(s)
Chromosomal Position Effects/genetics , Chromosome Mapping , Chromosomes, Human/genetics , Gene Rearrangement/genetics , Genetic Predisposition to Disease/genetics , Genome, Human/genetics , Chromosome Breakpoints , Gene Expression Regulation/genetics , Genetic Variation/genetics , Humans , In Situ Hybridization, Fluorescence , Karyotype , Phenotype , Translocation, Genetic/geneticsABSTRACT
X-linked Recessive Chondrodysplasia Punctata (CDPX1) is due to a defect in arylsulfatase E (ARSE), located on Xp22.3. Neither the substrate nor function of the encoded warfarin-sensitive arylsulfatase has been identified and molecular analysis remains the only confirmatory diagnostic test. Nevertheless, the majority of patients evaluated have not had identifiable mutations in ARSE, and thus far 23 patients have been reported. The major clinical features in these patients are also present in a group now recognized as phenocopies, due to vitamin K deficiency in early gestation or maternal autoimmune disease. We evaluated the ARSE gene in 11 patients who met clinical criteria for CDPX1. We amplified all exons and intronic flanking sequence from each patient, and investigated suspected deletions or rearrangements by southern analysis. We identified mutations in seven individuals. Of the remainder, three had maternal conditions that further expand the phenocopy group. Thus, this group might represent a proportion of the mutation-negative patients in previous studies. We extracted clinical information from all prior reports over the past decade and show that there are few distinguishing features on examination between these two groups of patients. This study supports heterogeneity for CDPX1-like phenotypes and sorting these out will help to define the biological pathway and genetic contributors.
Subject(s)
Arylsulfatases/genetics , Chondrodysplasia Punctata/enzymology , Chondrodysplasia Punctata/pathology , DNA Mutational Analysis , Genetic Diseases, X-Linked/enzymology , Genetic Diseases, X-Linked/pathology , Airway Obstruction/pathology , Cervical Vertebrae/abnormalities , Child , Child, Preschool , Chondrodysplasia Punctata/genetics , Chromosomes, Human, X/genetics , Genetic Diseases, X-Linked/genetics , Humans , Infant , Male , Vitamin K Deficiency/pathologyABSTRACT
Rett syndrome (OMIM 312750) is a progressive, X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene located on chromosome Xq28. The disorder is characterized by a period of normal development during the first 6-18months of life, followed by gradual loss of skills already gained, such as speech and purposeful movement of the hands. The majority of cases are sporadic and represent "de novo" mutations. In this study we summarize the results of diagnostic testing of 30 patients with Rett syndrome (RTT) or mental retardation of unknown etiology using bidirectional sequencing of the open reading frame of the MECP2 gene. Twenty different variants were identified in those patients including 12 missense (R133C, P152R, T158M, V300I, I303M, R306C, T311M, R344W, A358T, P384L, A443T, V481M), four nonsense (R168X, K192X, R255X, R270X), two deletion (E137_L386del, I293_S350del), and two frameshift (S291QfsX26, G343AfsX6) mutations. Seven of the twenty variants identified were novel mutations (E137_L386del, K192X, S291QfsX26, G343AfsX6, I293_S350del, P384L, and A443T). In the cases with novel or non-recurrent missense mutations, family studies were performed to investigate genotype-phenotype correlations. Our results demonstrate the importance of family studies and highlight the complexity of interpretation of MECP2 alterations, which may or may not be disease-associated.
Subject(s)
Methyl-CpG-Binding Protein 2/genetics , Mutation, Missense/genetics , Pathology, Molecular/methods , Rett Syndrome/diagnosis , Rett Syndrome/genetics , Family Health , Genetic Association Studies , Humans , MaleABSTRACT
BACKGROUND: Delaying chromosome studies after transfusion is common practice in many neonatal intensive care units (NICUs). Yet, no evidence exists to support this practice. PURPOSE: To investigate the effects of filtration and irradiation on chromosome detection, and to evaluate donor chromosome interference after transfusion. METHODS: Packed red blood cells (PRBCs) were evaluated by fluorescence in situ hybridization (FISH) and chromosome analyses. To evaluate donor leukocyte survival, blood was collected from female neonates who received male-donated PRBCs. RESULTS: Irradiated, leukodepleted blood had no Y chromosome detection by FISH. Irradiated, microaggregate filtered blood had Y chromosome detection in all samples by FISH but no metaphase growth. No donor chromosomes were detected in neonates after transfusion. CONCLUSIONS: Delaying chromosome or FISH analysis in transfused neonates who have received irradiated blood is unnecessary.